, Volume 6, Issue 4, pp 191-193

Atorvastatin decreases serum levels of advanced glycation end products (AGEs) in patients with type 2 diabetes

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access